Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51)Narrows 2025 projected revenue range to $1.6 - $2.0 billionImproves 2025 expected GAAP operating ...
18hon MSN
Carnival Cruise Line Hit with Lawsuit After 2 Passengers Allegedly Wake Up Covered in Bed Bug Bites
Carnival Cruise Line has been hit with a new lawsuit from two passengers who claim they woke up covered in bed bug bites ...
Speaking to the Daily Mail, Dr Donald Grant, GP and Senior Clinical Advisor at The Independent Pharmacy, said: 'Supplements ...
Dynavax is paying $30 million upfront for global rights to Vaxart’s investigational oral COVID-19 vaccine candidate, positioning the biotech to see phase 2b data before placing a bigger bet on the ...
1hon MSN
Flu warning as Surrey hospital trust fears this year's outbreak 'could be even worse' than last year
The St George's, Epsom and St Helier Hospital Group (GESH) NHS Trust is urging people to get their flu jabs as they "brace ...
TipRanks on MSN
Vaxart Partners with Dynavax for Oral COVID-19 Vaccine
Vaxart ( ($VXRT) ) has shared an announcement. On November 4, 2025, Vaxart entered into an exclusive license and collaboration agreement with ...
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, and Vaxart, Inc. (OTCQX: VXRT), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback